ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

KOD // Kodiak Sciences Inc

SPLC <GO> NASDAQ CIK 0001468748 ↗
Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$100.40 ▲ +3.36 (+3.46%)
MKT CAP: $6.31B • VOL: 1.17M
KOD // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>) SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO> CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NASDAQ
KOD // Kodiak Sciences Inc
GROSS MARGIN
41.0%
OP MARGIN
-13.3%
ROIC %
-35.0%
MKT CAP
$6.31B
UPSTREAM INPUTS ──► KOD OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO> REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO> REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX LIVE DB CROSS-COMPARISON
TICKER COMPANY LAST MKT CAP GROSS MGN OP MGN ROIC % EV/EBITDA REV YOY HEAD-TO-HEAD
KOD ★ Kodiak Sciences Inc $100.40 $6.31B 41.0% -13.3% -35.0% — +1.1% SUBJECT ISSUER
LLY Eli Lilly and Company $1,417.54 $1.33T 83.6% 40.2% 32.4% 36.4x +45.5% KOD VS LLY <GO>
JNJ Johnson & Johnson $273.20 $662.49B 67.9% 34.7% 25.5% 18.5x +6.0% KOD VS JNJ <GO>
ABBV AbbVie Inc. $294.89 $513.86B 70.2% 24.6% 29.0% 33.3x +8.6% KOD VS ABBV <GO>
UNH UnitedHealth Group Incorporated $406.97 $364.66B 88.6% 4.8% 11.5% 16.4x +6.5% KOD VS UNH <GO>
MRK Merck & Company Inc. Common Stock (new) $149.52 $361.02B 74.8% 34.3% 20.7% 15.3x +1.3% KOD VS MRK <GO>